Characteristic | Univariate | Multivariable | ||||||
---|---|---|---|---|---|---|---|---|
N | Event N | OR1 | 95% CI1 | p-value | OR1 | 95% CI1 | p-value | |
Age category | 189 | 95 | Â | Â | 0.180 | Â | Â | Â |
≤ 30 years |  |  | ref. | — |  | ref. | — |  |
> 30 years |  |  | 1.81 | 0.76, 4.54 |  | 1.27 | 0.41, 4.21 | 0.700 |
Marital status | 189 | 95 |  |  | < 0.001 |  |  |  |
Married |  |  | ref. | — |  | ref. | — |  |
Single |  |  | 0.80 | 0.10–4.96 |  | 2.32 | 0.24, 19.6 | 0.400 |
Widow |  |  | 11.4 | 3.18–73.2 |  | 11.9 | 2.53, 90.1 | 0.005 |
parity | 189 | 95 | Â | Â | 0.460 | Â | Â | Â |
≤ 4 children |  |  | ref. | — |  |  |  |  |
> 4 children |  |  | 1.27 | 0.68–2.38 |  |  |  |  |
Contraceptives types | 189 | 95 | Â | Â | 0.017 | Â | Â | Â |
None |  |  | ref. | — |  | ref. | — |  |
Hormonal-IUD |  |  | 1.43 | 0.28–10.9 |  | 1.85 | 0.28–16.4 | 0.500 |
Implant Jadele/Norplant |  |  | 0.40 | 0.15–0.96 |  | 1.18 | 0.37–3.86 | 0.800 |
injectable /Depo-provera |  |  | 0.28 | 0.11–0.67 |  | 0.81 | 0.25–2.63 | 0.700 |
Oral pill |  |  | 0.20 | 0.02–1.24 |  | 0.72 | 0.08–5.47 | 0.800 |
Contraceptive duration | 189 | 95 | Â | Â | 0.700 | Â | Â | Â |
≤ 20 |  |  | ref. | — |  |  |  |  |
> 20 years |  |  | 1.16 | 0.52–2.63 |  |  |  |  |
HIV status | 189 | 95 |  |  | < 0.001 |  |  |  |
negative |  |  | ref. | — |  | ref. | — |  |
positive |  |  | 2.79 | 1.56–5.10 |  | 2.43 | 1.25, 4.79 | 0.009 |
HSV2 | 189 | 95 | Â | Â | 0.024 | Â | Â | Â |
Negative |  |  | ref. | — |  | ref. | — |  |
Positive |  |  | 2.41 | 1.12–5.46 |  | 2.70 | 1.15, 6.69 | 0.026 |
Chlamydia | 189 | 95 |  |  | < 0.001 |  |  |  |
Negative |  |  | ref. | — |  | ref. | — |  |
Positive |  |  | 3.83 | 1.84–8.51 |  | 3.63 | 1.61, 8.65 | 0.002 |